title: Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
authors.affiliation: Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Greenstein
authors.forename: S
authors.initials: S
authors.lastname: Sun
authors.forename: R S
authors.initials: RS
authors.lastname: Schechner
authors.forename: V A
authors.initials: VA
authors.lastname: Tellis
mesh_terms: D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D060908:CTLA-4 Antigen; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000517:prevention & control; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods*; D007421:Intestine, Small / Q000637:transplantation*; D017710:Lymphocyte Transfusion; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013154:Spleen; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D000961:Antilymphocyte Serum; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D000069594:Abatacept